← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Sab Biotherapeutics, Inc.
Sioux Falls, SD
$3,044,267
Total funding
2
Grants
Funding over time
peak $1.2M · FY2016–20$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,044,267 · 2
By mechanism
R44$3,044,267 · 2
Investigators at Sab Biotherapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy$1,000,000
R44 · FY2019 · AI
Production of therapeutic human polyclonal antibodies against influenza viruses$756,080
R44 · FY2016 · AI
Production of therapeutic human polyclonal antibodies against influenza viruses$670,476
R44 · FY2017 · AI
Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy$418,106
R44 · FY2020 · AI
Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy$199,605
R44 · FY2019 · AI